Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb).
- DOI
- 10.1186/s12879-023-08925-2
- Published
- 2024 Jan 6
- Container
- BMC infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12879-023-08925-2,
title = {Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb).},
author = {Tengelmann C and Joos S and Kaußner Y and Malzahn U and Lunden L and Klug A and Häusler KG and Escales C and Maetzler W and Hügen K and Zolk O and Heuschmann PU and Förster C and Kaduszkiewicz H and Gágyor I},
year = {2024},
journal = {BMC infectious diseases},
doi = {10.1186/s12879-023-08925-2},
url = {https://doi.org/10.1186/s12879-023-08925-2}
}RIS
TY - JOUR TI - Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb). AU - Tengelmann C AU - Joos S AU - Kaußner Y AU - Malzahn U AU - Lunden L AU - Klug A AU - Häusler KG AU - Escales C AU - Maetzler W AU - Hügen K AU - Zolk O AU - Heuschmann PU AU - Förster C AU - Kaduszkiewicz H AU - Gágyor I PY - 2024 JO - BMC infectious diseases DO - 10.1186/s12879-023-08925-2 UR - https://doi.org/10.1186/s12879-023-08925-2 ER -
APA
C, T., S, J., Y, K., U, M., L, L., A, K., KG, H., C, E., W, M., K, H., O, Z., PU, H., C, F., H, K., & I, G. (2024). Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb).. BMC infectious diseases. https://doi.org/10.1186/s12879-023-08925-2
Source records
- pubmed · retrieved 2026-09-27T11:03:42.305Z